|
0
|
|
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.
(nejm.org)
|
Al-Samkari H
…
Soff GA
New England Journal of Medicine
2026-03-12
|
#cancer
#clinical trial
#chemotherapy
#thrombocytopenia
|
|
0
|
|
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
(nejm.org)
|
Castellucci LA
…
Rodger M
New England Journal of Medicine
2026-03-12
|
#clinical trial
#anticoagulation
#hemorrhage
#thromboembolism
|
|
0
|
|
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial.
(bmj.com)
|
Peng Z
…
Shen L
BMJ
2026-03-12
|
#cancer
#clinical trial
#immunotherapy
#chemotherapy
#gastric
|
|
0
|
|
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.
(nejm.org)
|
Al-Sawaf O
…
Hallek M
New England Journal of Medicine
2026-03-12
|
#clinical trial
#immunotherapy
#chemotherapy
#leukemia
|
|
0
|
|
DB-OTO Gene Therapy for Inherited Deafness.
(nejm.org)
|
Valayannopoulos V
…
Whitton JP
New England Journal of Medicine
2026-03-12
|
#clinical trial
#gene therapy
#aav
#deafness
|